FLOSSBACH VON STORCH SE - QIAGEN NV ownership

QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 171 filers reported holding QIAGEN NV in Q3 2014. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
FLOSSBACH VON STORCH SE ownership history of QIAGEN NV
ValueSharesWeighting
Q4 2016$6,594,000
+1.9%
235,0000.0%0.11%
-0.9%
Q3 2016$6,470,000
+49.4%
235,000
+17.5%
0.11%
+45.9%
Q2 2016$4,330,000
-57.5%
200,000
-56.2%
0.07%
-54.3%
Q1 2016$10,183,000
-18.5%
457,000
-0.2%
0.16%
-23.9%
Q4 2015$12,487,000
-3.0%
458,000
-8.4%
0.21%
-4.9%
Q3 2015$12,871,000
-20.4%
499,900
-24.1%
0.22%
-28.4%
Q2 2015$16,174,000
-7.8%
658,500
-5.5%
0.31%
-21.0%
Q1 2015$17,542,000
+15.1%
696,500
+7.0%
0.40%
+10.6%
Q4 2014$15,240,000
-24.4%
650,662
-26.5%
0.36%
-18.1%
Q3 2014$20,147,000
-7.8%
884,662
-5.9%
0.44%
-16.4%
Q2 2014$21,843,000939,6620.52%
Other shareholders
QIAGEN NV shareholders Q3 2014
NameSharesValueWeighting ↓
Tikvah Management LLC 369,425$9,032,0006.36%
Hardman Johnston Global Advisors LLC 4,586,856$112,149,0005.99%
Eclectica Asset Management LLP 90,950$2,223,0002.21%
Douglas C. Lane & Associates, Inc. 1,970,371$48,176,0001.46%
HARDING LOEVNER LP 6,978,369$170,621,0001.27%
CRAMER ROSENTHAL MCGLYNN LLC 3,911,835$95,644,0000.77%
PLATINUM INVESTMENT MANAGEMENT LTD 1,781,076$43,547,0000.76%
GLG Partners LP 1,220,148$29,833,0000.71%
Sivik Global Healthcare LLC 49,451$1,209,0000.61%
PRIMECAP MANAGEMENT CO/CA/ 22,087,404$540,037,0000.59%
View complete list of QIAGEN NV shareholders